NTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nutrien Ltd (NTR) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and favorable industry trends outweigh the technical neutrality and hedge fund selling activity. The stock is well-positioned to benefit from elevated fertilizer prices due to geopolitical disruptions, making it a solid long-term investment.
The technical indicators are neutral. The MACD histogram is negative (-0.346) but contracting, RSI is at 44.643 in the neutral zone, and moving averages are converging. Key support and resistance levels are S1: 70.17, Pivot: 72.533, and R1: 74.895. The stock is trading near its pivot level, suggesting no immediate breakout or breakdown.
Strong financial performance in Q4 2025 with revenue up 5.14% YoY, net income up 405.31%, and EPS up 413.04%.
Elevated fertilizer prices due to geopolitical disruptions (Iran conflict) are expected to persist, benefiting Nutrien's operations.
Analysts have raised price targets, with multiple firms maintaining Outperform or Overweight ratings.
Positive sentiment in the agriculture sector and stabilization trends in Q1.
Hedge funds are selling, with selling activity up 116.85% last quarter.
UBS downgraded the stock to Sell, citing potential pricing pressure in the potash market later in the decade.
Technical indicators are neutral, with no strong bullish signals.
Nutrien reported strong financials for Q4 2025: Revenue increased by 5.14% YoY to $5.34 billion, net income surged by 405.31% YoY to $571 million, EPS rose by 413.04% YoY to 1.18, and gross margin improved by 13.59% YoY to 35.36%. These figures highlight robust growth and operational efficiency.
Analyst sentiment is mostly positive. Recent upgrades include price targets ranging from $75 to $100, with Outperform and Overweight ratings from firms like RBC Capital, Morgan Stanley, and Wells Fargo. However, UBS downgraded the stock to Sell with a price target of $67, citing concerns about potash pricing pressure in the long term.
